Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a single chain antibody fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its pipeline focuses on cytokines, a class of cell signaling peptides that, among other important functions, serve as potent immunomodulatory agents. The company was founded by Pankaj Mohan and John K. Cini in 2011 and is headquartered in Princeton, NJ.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13
Frequently Asked Questions
What is Market Cap of Sonnet BioTherapeutics Holdings Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Sonnet BioTherapeutics Holdings Inc market cap is $39.85M.
What is the 52-week high for Sonnet BioTherapeutics Holdings Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Sonnet BioTherapeutics Holdings Inc 52 week high is $19.30 as of September 14, 2025.
What is the 52-week low for Sonnet BioTherapeutics Holdings Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Sonnet BioTherapeutics Holdings Inc 52 week low is $1.08 as of September 14, 2025.
What is Sonnet BioTherapeutics Holdings Inc stock price today?
Sonnet BioTherapeutics Holdings Inc stock price today is $5.90.
What was Sonnet BioTherapeutics Holdings Inc stock price yesterday?
Sonnet BioTherapeutics Holdings Inc stock price yesterday was $3.96.
What is the PE ratio of Sonnet BioTherapeutics Holdings Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Sonnet BioTherapeutics Holdings Inc’s P/E ratio is -0.72.
What is the Price-to-Book ratio of Sonnet BioTherapeutics Holdings Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Sonnet BioTherapeutics Holdings Inc P/B ratio is -6.4544.
What is the 50-day moving average of Sonnet BioTherapeutics Holdings Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Sonnet BioTherapeutics Holdings Inc 50-day moving average is $4.15.
How many employess does Sonnet BioTherapeutics Holdings Inc has?
Sonnet BioTherapeutics Holdings Inc has 13 employees.